TTrialPathMatch Me to Trials
← Back to trials
RecruitingOrnithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

Eligible age

0.6–1.3 yrs

Accepts

All genders

Locations

2 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This LTFU is being conducted to assess long-term safety and durability of response in participants dosed with IP in a parent protocol, and to collect longitudinal natural history in enrolled but not dosed participants who also participated in a parent protocol.

Sponsor: iECURE, Inc.

You may qualify if…

  • ✓ 1. Enrolled in an iECURE parent protocol and have either completed or discontinued that protocol
  • ✓ 2. Participant parent(s)/LAR is willing and able to adhere to the protocol requirements.
  • ✓ 3. Consent was obtained by the participants parent(s)/LAR (and participant assent, where applicable), prior to any study-related data being collected.

You may not qualify if…

  • ✕ 1\. Participants who enroll into an interventional drug or gene therapy clinical trial utilizing an IP other than the IP provided in the parent protocol will be excluded from this protocol.

Where it's recruiting

Colorado

Aurora

New York

New York

Source: ClinicalTrials.gov · NCT06805695 · last updated 2026-11-05

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protoco · TrialPath